Well Lead Medical Co

Well Lead Medical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Well Lead Medical Co (603309.SS) as of Oct 31, 2026 is 304.60 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 297.18 M CNY — a change of 2.50% (higher).

EBITDA

304.60 MCNY

YoY

2.50%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Well Lead Medical Co is 2025 304.60 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Well Lead Medical Co was 2024 297.18 M CNY. It decreases by 2.50% higher compared to the previous year.

The Well Lead Medical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
80.13 M CNY
Jan 1, 2019
181.54 M CNY
Jan 1, 2020
220.47 M CNY
Jan 1, 2021
168.60 M CNY
Jan 1, 2022
237.84 M CNY
Jan 1, 2023
271.94 M CNY
Jan 1, 2024
297.18 M CNY
Jan 1, 2025
304.60 M CNY
The Well Lead Medical Co EBITDA history
YEAREBITDAYoY
304.60 MCNY+2.50%
297.18 MCNY+9.28%
271.94 MCNY+14.33%
237.84 MCNY+41.07%
168.60 MCNY-23.52%
220.47 MCNY+21.44%
181.54 MCNY+126.56%
80.13 MCNY+2.30%
78.32 MCNY-11.56%
88.57 MCNY-11.85%
100.47 MCNY+12.70%
89.15 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Well Lead Medical Co Stock analysis

What does Well Lead Medical Co do? Well Lead Medical Co., Ltd. generates revenue through the research, development, production, and sales of medical equipment for anesthesia, urology, nursing, respiratory, and hemodialysis applications. The company's major products include endotracheal intubations, urethral catheters, laryngeal masks, and hemodialysis catheters, which are used in clinical settings such as hospitals, surgeries, treatments, first aid, and nursing. Domestic and overseas markets are the primary channels for distributing these products, serving healthcare facilities that require specialized medical equipment for surgical procedures, emergency care, and patient treatment. The firm targets hospitals, surgical centers, and healthcare providers as key customers, leveraging its product range to address needs in anesthesia, urology, respiratory care, and hemodialysis. By focusing on clinical applications in surgery, treatment, emergency care, and nursing, Well Lead Medical ensures its equipment meets the demands of medical professionals across various hospital departments. The company's domestic and international distribution network supports its presence in both local and global healthcare markets. Well Lead Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Well Lead Medical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Well Lead Medical Co is 304.60 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Well Lead Medical Co changed from 297.18 M CNY to 304.60 M CNY, representing a 2.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Well Lead Medical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Well Lead Medical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Well Lead Medical Co

All Key Metrics — Well Lead Medical Co